Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke

Craig S. Anderson(Royal Prince Alfred Hospital), John Chalmers(UNSW Sydney), Tsong‐Hai Lee(Chang Gung University), Laurent Billot(The George Institute for Global Health), Christopher Levi(John Hunter Hospital), Andrew M. Demchuk(University of Calgary), Yining Huang(Nanjing University of Chinese Medicine), Xia Wang(University of Leicester), Pablo M. Lavados(University of Leicester), Octávio Marques Pontes‐Neto(Universidade de São Paulo), Vijay K. Sharma(Cornell University), Geoffrey A. Donnan(The Royal Melbourne Hospital), Sheila Cristina Ouriques Martins(Universidade Federal do Rio Grande do Sul), Mark Woodward(UNSW Sydney), Stefano Ricci(Città di Castello Hospital), Thompson Robinson(University of Leicester), Verónica V. Olavarría(Universidad del Desarrollo), Richard I. Lindley(Westmead Hospital), Jeyaraj Pandian(Christian Medical College, Vellore), Christine Roffe(Keele University), Philip M. Bath(Nottingham University Hospitals NHS Trust), Federico Silva(The George Institute for Global Health), Mark Parsons(UNSW Sydney), Hisatomi Arima(University of Leicester), Qiang Li(Fuzhou University), Xiaoying Chen(The University of Sydney), Jong S. Kim(Ajou University Hospital), Yongjun Cao(Soochow University), Guofang Chen(Shanxi Agricultural University), Joseph P. Broderick(The George Institute for Global Health), Ji‐Guang Wang(Ruijin Hospital)
New England Journal of Medicine
May 10, 2016
Cited by 437


Related Papers